Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival

Go back to Relay Therapeutics (RLAY) Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
(NASDAQ: RLAY) Delayed: 18.90 -0.21 (1.1%)
Previous Close $19.11    52 Week High
Open $18.76    52 Week Low
Day High $19.19    P/E N/A 
Day Low $18.76    EPS
Volume 3,275,030